ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 292 filers reported holding ICU MED INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $238,202 | +4.7% | 1,444 | 0.0% | 0.00% | – |
| Q4 2022 | $227,401 | +4.8% | 1,444 | 0.0% | 0.00% | – |
| Q3 2022 | $217,000 | -84.5% | 1,444 | -83.0% | 0.00% | -100.0% |
| Q2 2022 | $1,400,000 | -79.4% | 8,518 | -72.1% | 0.00% | -66.7% |
| Q1 2022 | $6,809,000 | +19.2% | 30,584 | +27.1% | 0.01% | +20.0% |
| Q4 2021 | $5,712,000 | -36.3% | 24,068 | -37.3% | 0.01% | -37.5% |
| Q3 2021 | $8,964,000 | +47.0% | 38,409 | +29.6% | 0.01% | +60.0% |
| Q2 2021 | $6,099,000 | -13.3% | 29,637 | -13.4% | 0.01% | -28.6% |
| Q1 2021 | $7,033,000 | +38.5% | 34,234 | +44.6% | 0.01% | +40.0% |
| Q4 2020 | $5,077,000 | -35.7% | 23,671 | -45.2% | 0.01% | -37.5% |
| Q3 2020 | $7,893,000 | +4.6% | 43,186 | +5.5% | 0.01% | -11.1% |
| Q2 2020 | $7,547,000 | +45.5% | 40,946 | +59.3% | 0.01% | +12.5% |
| Q1 2020 | $5,188,000 | -19.0% | 25,710 | -24.9% | 0.01% | +14.3% |
| Q4 2019 | $6,402,000 | -50.5% | 34,215 | -57.8% | 0.01% | -56.2% |
| Q3 2019 | $12,935,000 | +405.9% | 81,044 | +698.5% | 0.02% | +433.3% |
| Q2 2019 | $2,557,000 | +130.6% | 10,150 | +119.0% | 0.00% | +200.0% |
| Q1 2019 | $1,109,000 | -33.4% | 4,634 | -36.1% | 0.00% | -50.0% |
| Q4 2018 | $1,666,000 | -13.0% | 7,253 | +7.1% | 0.00% | 0.0% |
| Q3 2018 | $1,914,000 | -84.9% | 6,770 | -84.3% | 0.00% | -87.5% |
| Q2 2018 | $12,695,000 | +695.4% | 43,231 | +583.7% | 0.02% | +1500.0% |
| Q1 2018 | $1,596,000 | +194.5% | 6,323 | +152.2% | 0.00% | – |
| Q4 2017 | $542,000 | +142.0% | 2,507 | +107.7% | 0.00% | – |
| Q3 2017 | $224,000 | -57.3% | 1,207 | -60.3% | 0.00% | -100.0% |
| Q2 2017 | $524,000 | -13.0% | 3,040 | -22.8% | 0.00% | 0.0% |
| Q1 2017 | $602,000 | -32.1% | 3,940 | -34.6% | 0.00% | -50.0% |
| Q4 2016 | $887,000 | -63.1% | 6,022 | -68.4% | 0.00% | -50.0% |
| Q3 2016 | $2,407,000 | +14.4% | 19,047 | +2.1% | 0.00% | 0.0% |
| Q2 2016 | $2,104,000 | +57.2% | 18,657 | +45.1% | 0.00% | +100.0% |
| Q1 2016 | $1,338,000 | -49.8% | 12,854 | -45.6% | 0.00% | -50.0% |
| Q4 2015 | $2,667,000 | -76.0% | 23,644 | -76.7% | 0.00% | -75.0% |
| Q3 2015 | $11,095,000 | +3.2% | 101,324 | -9.8% | 0.02% | 0.0% |
| Q2 2015 | $10,750,000 | +0.2% | 112,374 | -2.5% | 0.02% | 0.0% |
| Q1 2015 | $10,730,000 | +14.1% | 115,200 | +0.3% | 0.02% | +33.3% |
| Q4 2014 | $9,404,000 | +345.1% | 114,825 | +248.8% | 0.01% | +300.0% |
| Q3 2014 | $2,113,000 | -43.7% | 32,919 | -46.7% | 0.00% | -40.0% |
| Q2 2014 | $3,754,000 | +48.6% | 61,726 | +46.3% | 0.01% | +25.0% |
| Q1 2014 | $2,527,000 | +216.7% | 42,195 | +281.1% | 0.00% | +100.0% |
| Q2 2013 | $798,000 | – | 11,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |